Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Алкогольная болезнь печени: фокус на лечение гепатита
С.И.Пиманов. Алкогольная болезнь печени: фокус на лечение гепатита. Consilium Medicum. Гастроэнтерология (Прил.). 2012; 1: 80-85.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic Liver Disease. Am J Gastroenterol 2010; 105: 14–32.
2. Gramenzi A, Caputo F, Biselli M et al. Review article: alcoholic liver disease – pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006; 24 (8): 1151–61.
3. Singer M, Feick P, Gerloff A. Alcohol and smoking. In.: Environment and lifestyle – effects on disorders of the digestive tract. Ed. H.E.Blum, R.H.Hunt, J.Scholmerich. Karger 2011; 177–183.
4. Seth D, Haber P, Wing-Kin Syn et al. Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances. J Gastroenterol Hepatol 2011; 26: 1089–105.
5. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613–9.
6. Острые отравления этанолом и его суррогатами. Под ред. Ю.Ю.Бонитенко. СПб.: «ЭЛБИ-СПб», 2005.
7. Kuntz E, Kuntz H-D. Hepatology. Principles and Practice. Heidelberg: Springer Medizin Verlag, 2006.
8. Ceccanti M et al. Acute Alcoholic Hepatitis. J Clin Gastroenterol 2006; 40: 833–41.
9. Шульпекова Ю.О. Таргетная терапия заболеваний печени. Справ. поликлин. врача. 2009; 5: 21–5.
10. Подымова С.Д. Адеметионин: фармакологические эффекты и клиническое применение препарата. РМЖ. 2010; 18 (13): 800–6.
11. Пиманов С.И. Острый алкогольный гепатит. Cons. Med. Гастроэнтерология (Прил.). 2008; 2: 67–72.
12. Scaglioni F et al. ASH and NASH. In.: Environment and lifestyle – effects on disorders of the digestive tract. Ed. H.E.Blum, R.H.Hunt, J.Scholmerich. Karger 2011; 202–10.
13. Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database of Systematic Reviews. 2006; Issue 2, Art. No.: CD002235.
14. Frezza M. A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis. Ann Ital Med Int 1993; 8 (Suppl.): 48S–51S.
15. Hardy M, Coulter I, Morton SC et al. S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease. Evidence Report/Technology Assessment Number 64 (Prepared by Southern California Evidence-based Practice Center under Contract No. 290-97-0001). AHRQ Publication No. 02-E034. Rockville, MD: Agency for Healthcare Research and Quality. October 2002.
16. Mato JM, Camara J, Fernandez de Paz J et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999; 30(6): 1081–9.
2. Gramenzi A, Caputo F, Biselli M et al. Review article: alcoholic liver disease – pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006; 24 (8): 1151–61.
3. Singer M, Feick P, Gerloff A. Alcohol and smoking. In.: Environment and lifestyle – effects on disorders of the digestive tract. Ed. H.E.Blum, R.H.Hunt, J.Scholmerich. Karger 2011; 177–183.
4. Seth D, Haber P, Wing-Kin Syn et al. Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances. J Gastroenterol Hepatol 2011; 26: 1089–105.
5. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613–9.
6. Острые отравления этанолом и его суррогатами. Под ред. Ю.Ю.Бонитенко. СПб.: «ЭЛБИ-СПб», 2005.
7. Kuntz E, Kuntz H-D. Hepatology. Principles and Practice. Heidelberg: Springer Medizin Verlag, 2006.
8. Ceccanti M et al. Acute Alcoholic Hepatitis. J Clin Gastroenterol 2006; 40: 833–41.
9. Шульпекова Ю.О. Таргетная терапия заболеваний печени. Справ. поликлин. врача. 2009; 5: 21–5.
10. Подымова С.Д. Адеметионин: фармакологические эффекты и клиническое применение препарата. РМЖ. 2010; 18 (13): 800–6.
11. Пиманов С.И. Острый алкогольный гепатит. Cons. Med. Гастроэнтерология (Прил.). 2008; 2: 67–72.
12. Scaglioni F et al. ASH and NASH. In.: Environment and lifestyle – effects on disorders of the digestive tract. Ed. H.E.Blum, R.H.Hunt, J.Scholmerich. Karger 2011; 202–10.
13. Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database of Systematic Reviews. 2006; Issue 2, Art. No.: CD002235.
14. Frezza M. A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis. Ann Ital Med Int 1993; 8 (Suppl.): 48S–51S.
15. Hardy M, Coulter I, Morton SC et al. S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease. Evidence Report/Technology Assessment Number 64 (Prepared by Southern California Evidence-based Practice Center under Contract No. 290-97-0001). AHRQ Publication No. 02-E034. Rockville, MD: Agency for Healthcare Research and Quality. October 2002.
16. Mato JM, Camara J, Fernandez de Paz J et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999; 30(6): 1081–9.
Авторы
С.И.Пиманов
Витебский государственный медицинский университет
Витебский государственный медицинский университет
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.